pubmed-article:20700408 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20700408 | lifeskim:mentions | umls-concept:C1848822 | lld:lifeskim |
pubmed-article:20700408 | lifeskim:mentions | umls-concept:C0007222 | lld:lifeskim |
pubmed-article:20700408 | lifeskim:mentions | umls-concept:C0948265 | lld:lifeskim |
pubmed-article:20700408 | lifeskim:mentions | umls-concept:C0681679 | lld:lifeskim |
pubmed-article:20700408 | pubmed:dateCreated | 2010-8-11 | lld:pubmed |
pubmed-article:20700408 | pubmed:abstractText | Background. Renal disease is commonly described as a complication of metabolic syndrome (MetS) but some recent studies suggest that Chronic Kidney disease (CKD) may actually antecede MetS. Few studies have explored the predictive utility of co-clustering CKD with MetS for cardiovascular disease (CVD) mortality. Methods. Data from a nationally representative sample of United States adults (NHANES) was utilized. A sample of 13115 non-pregnant individuals aged >/=35 years, with available follow-up mortality assessment was selected. Multivariable Cox Proportional hazard regression analysis techniques explored the relationship between co-clustered CKD, MetS and CVD mortality. Bayesian analysis techniques tested the predictive accuracy for CVD Mortality of two models using co-clustered MetS and CKD and MetS alone. Results. Co-clustering early and late CKD respectively resulted in statistically significant higher hazard for CVD mortality (HR = 1.80, CI = 1.45-2.23, and HR = 3.23, CI = 2.56-3.70) when compared with individuals with no MetS and no CKD. A model with early CKD and MetS has a higher predictive accuracy (72.0% versus 67.6%), area under the ROC (0.74 versus 0.66), and Cohen's kappa (0.38 versus 0.21) than that with MetS alone. Conclusion. The study findings suggest that the co-clustering of early CKD with MetS increases the accuracy of risk prediction for CVD mortality. | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:language | eng | lld:pubmed |
pubmed-article:20700408 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20700408 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
pubmed-article:20700408 | pubmed:issn | 2090-0732 | lld:pubmed |
pubmed-article:20700408 | pubmed:author | pubmed-author:FaixJJ | lld:pubmed |
pubmed-article:20700408 | pubmed:author | pubmed-author:NorrisKeithK | lld:pubmed |
pubmed-article:20700408 | pubmed:author | pubmed-author:MartinsDavidD | lld:pubmed |
pubmed-article:20700408 | pubmed:author | pubmed-author:OgunyemiOmolo... | lld:pubmed |
pubmed-article:20700408 | pubmed:author | pubmed-author:AniChizobamC | lld:pubmed |
pubmed-article:20700408 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20700408 | pubmed:volume | 2010 | lld:pubmed |
pubmed-article:20700408 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20700408 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20700408 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20700408 | pubmed:articleTitle | Renal dysfunction, metabolic syndrome and cardiovascular disease mortality. | lld:pubmed |
pubmed-article:20700408 | pubmed:affiliation | Department of Medicine, Charles Drew University of Medicine and Science, 1731 E 20th Street, Los Angeles, CA 90059, USA. | lld:pubmed |
pubmed-article:20700408 | pubmed:publicationType | Journal Article | lld:pubmed |